Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock COMPARATIVE CLINICAL SCIENCE FOUNDATION's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteCOMPARATIVE CLINICAL SCIENCE FOUNDATION
CLARISSA HOUSE, HIGH STREET WAPPENHAM, TOWCESTER, NORTHAMPTONSHIRE, NN12 8SN
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
COMPARATIVE CLINICAL SCIENCE FOUNDATION
Private Limited by guarantee without Share Capital Exempt from using Limited
Company is dissolved
18 June 2004
72110 Research and experimental development on biotechnology - To establish a permanent stream of funding for comparative clinical research to be distributed through a panel of experts set up by the medical research council to ensure the highest quality of peer-reviewed research. A registered charity, limited by guarantee. T/O = Total Incoming Resources.
Available to 06 Jan 2016. Next accounts due by 06 Oct 2017
Is COMPARATIVE CLINICAL SCIENCE FOUNDATION in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| MR ROBERT MICHAEL JAMES GASCOYNE CECIL | Director | ||
| PROF ALUN WILLIAMS | Director | ||
| SIR GRAEME ROBERTSON DAWSON CATTO | Director | ||
| MR BRUCE VIVASH JONES | Director | ||
| THE EARL OF SELBORNE JOHN ROUNDELL PALMER | Director | ||
| PROF ALEXANDER JOHN TREES | Director | ||
| MR JULIAN ANDREW WELLS | Director |
Previous Directors & Secretaries
Mortgages and Charges
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £5,762.00 | £17,079.00 | £15,568.00 | £11,389.00 | £6,468.00 |
| Net Worth | £4,958.00 | £15,753.00 | £13,678.00 | £10,030.00 | £5,347.00 |
| Total Current Liabilities | £804.00 | £1,326.00 | £1,890.00 | £1,359.00 | £1,121.00 |
| Total Current Assets | £5,762.00 | £17,079.00 | £15,568.00 | £11,389.00 | £6,468.00 |
Frequently Asked Questions about COMPARATIVE CLINICAL SCIENCE FOUNDATION
Detailed answers about COMPARATIVE CLINICAL SCIENCE FOUNDATION, including incorporation, status, business activity, and accounts information.
When was COMPARATIVE CLINICAL SCIENCE FOUNDATION founded?
COMPARATIVE CLINICAL SCIENCE FOUNDATION was officially incorporated on 18 June 2004 and is registered under company number 05157674. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is COMPARATIVE CLINICAL SCIENCE FOUNDATION?
Private Limited by guarantee without Share Capital Exempt from using Limited. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of COMPARATIVE CLINICAL SCIENCE FOUNDATION?
COMPARATIVE CLINICAL SCIENCE FOUNDATION's current status is Dissolved. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does COMPARATIVE CLINICAL SCIENCE FOUNDATION do?
COMPARATIVE CLINICAL SCIENCE FOUNDATION operates in the following sector: 72110 Research and experimental development on biotechnology - To establish a permanent stream of funding for comparative clinical research to be distributed through a panel of experts set up by the medical research council to ensure the highest quality of peer-reviewed research. A registered charity, limited by guarantee. T/O = Total Incoming Resources. . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is COMPARATIVE CLINICAL SCIENCE FOUNDATION's registered address?
The registered office address of COMPARATIVE CLINICAL SCIENCE FOUNDATION is Clarissa House, High Street Wappenham, Towcester, Northamptonshire, NN12 8SN. This is the official address filed with Companies House for legal and statutory correspondence.
Is COMPARATIVE CLINICAL SCIENCE FOUNDATION financially stable?
Based on the latest accounts up to 06 Jan 2016, COMPARATIVE CLINICAL SCIENCE FOUNDATION has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 06 Oct 2017. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.